540788 Stock Overview
Owns, manages, runs, and administers various diagnostics centers primarily in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Aspira Pathlab & Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹55.66 |
| 52 Week High | ₹57.30 |
| 52 Week Low | ₹25.00 |
| Beta | -0.23 |
| 11 Month Change | 29.35% |
| 3 Month Change | 79.55% |
| 1 Year Change | 44.57% |
| 33 Year Change | -45.86% |
| 5 Year Change | 52.49% |
| Change since IPO | 293.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540788 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 11.0% | 2.7% | 1.8% |
| 1Y | 44.6% | 46.4% | 36.8% |
Return vs Industry: 540788 underperformed the Indian Healthcare industry which returned 46.4% over the past year.
Return vs Market: 540788 exceeded the Indian Market which returned 36.8% over the past year.
Price Volatility
| 540788 volatility | |
|---|---|
| 540788 Average Weekly Movement | 8.6% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540788's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 540788's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 115 | Pankaj Shah | www.aspiradiagnostics.com |
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. It offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016.
Aspira Pathlab & Diagnostics Limited Fundamentals Summary
| 540788 fundamental statistics | |
|---|---|
| Market cap | ₹572.91m |
| Earnings (TTM) | -₹19.09m |
| Revenue (TTM) | ₹152.38m |
3.8x
P/S Ratio-30.0x
P/E RatioIs 540788 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540788 income statement (TTM) | |
|---|---|
| Revenue | ₹152.38m |
| Cost of Revenue | ₹104.19m |
| Gross Profit | ₹48.19m |
| Other Expenses | ₹67.29m |
| Earnings | -₹19.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 12, 2024
| Earnings per share (EPS) | -1.85 |
| Gross Margin | 31.63% |
| Net Profit Margin | -12.53% |
| Debt/Equity Ratio | 27.4% |
How did 540788 perform over the long term?
See historical performance and comparison